New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Tirzepatide could result in net lifetime health care costs of more than $16 trillion in the U.S. if all people eligible to ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

When we feed the body correctly, we can influence the same systems that drugs like Mounjaro target - helping regulate ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

Eli Lilly has decided to wait for the readout of the second of its two phase 3 trials for tirzepatide in obesity, rather than filing on the strength of its first, positive study. When Lilly ...

The results from a sub-population of patients in Lilly's SURMOUNT-1 trial suggest that tirzepatide could provide an alternative that, at least in theory, could require less dramatic lifestyle changes.

Without insurance, Mounjaro costs approximately $1,069.08 per 4-week supply. You can get Mounjaro online through a licensed medical professional on a telehealth platform. PlushCare offers Mounjaro ...

Zepbound is an injectable medication approved by the U.S. Food and Drug Administration (FDA) for weight loss, and its key ingredient is tirzepatide. While Zepbound may be a powerful tool for ...